Boundless Bio (BOLD) Financials: Revenue & Earnings

BOLD price $2.50 +0.09 +3.73%

Ticker
BOLD
Price
$2.50
Change
+0.09 +3.73%
Market cap ?
$56.87M
P/E ?
-0.84
Dividend yield ?
0.00%
Beta ?
0.38
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
50
Value
50
Quality
49
Growth
50

Stocklytics score rationale: value 50, quality 49, growth 50.

Financials

20162017201820212022202320242025
00000000

Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials…

Fair value

BOLD fair value Not meaningful. Price $2.50.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare BOLD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.56——
2026-08-04-1.06-1.06——
2026-05-08-0.60-0.51——
2026-03-09-0.58-0.44——
2025-11-05-0.62-0.53——
2025-08-05-0.70-0.75——
2025-05-09-0.71-0.68——
2025-03-27-0.74-0.74——
2024-11-07-0.74-0.76——
2024-08-12-0.77-0.78——
2024-05-13-12.27-0.55——
2024-03-06-9.76———
2019-11-07-1.00-1.07——
2019-08-06-1.01-1.04——
2019-05-07-1.13-0.89——
2019-02-27-0.84-0.91——
2018-11-06-0.97-0.88——
2018-08-07-0.85-0.78——
2018-05-09-0.74-0.80——
2018-03-08-0.82-0.90——
2017-11-14-0.88-0.89——
2017-08-10-0.87-0.79——
2017-05-11-0.83-0.92——
2017-03-09-0.91-0.75——
2016-11-10-0.94-0.65——
2016-08-31-6.43-1.33——
2016-07-20————

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-26TANG KEVINBuy9.61K$2.3822.86K
2026-10-23TANG KEVINBuy6.23K$2.3814.84K
2026-10-22TANG KEVINBuy5.80K$2.4013.92K
2026-10-20TANG KEVINBuy220$2.37521
2026-10-19TANG KEVINBuy18.28K$2.3342.59K
2026-10-19TANG KEVINBuy12.79K$2.3429.93K
2026-10-16TANG KEVINBuy118.19K$2.34276.55K
2026-08-26TANG KEVINSell18.30K$2.9754.35K
2026-07-21TANG KEVINBuy2.98K$2.447.26K
2026-07-20TANG KEVINBuy1.62K$2.443.96K
2026-07-17TANG KEVINBuy265$2.44647
2026-07-16TANG KEVINBuy18.49K$2.4445.12K
2026-07-15TANG KEVINBuy1.60K$2.443.90K
2026-07-14TANG KEVINBuy43.88K$2.43106.62K
2026-07-13TANG KEVINBuy48.21K$2.42116.67K
2026-07-10TANG KEVINBuy43.37K$2.43105.38K
2026-07-09TANG KEVINBuy7$2.4817
2026-07-08TANG KEVINBuy14.34K$2.4635.27K
2026-07-07TANG KEVINBuy15.81K$2.4839.21K
2026-07-06TANG KEVINBuy27.06K$2.4967.38K
2026-07-02TANG KEVINBuy9.82K$2.4924.45K
2026-07-01CRANDELL KEITHBuy16.00K$1.0316.48K
2026-07-01CRANDELL KEITHSell16.00K$2.4939.84K
2026-07-01CRANDELL KEITHSell16.00K$1.0316.48K
2026-07-01ARCH Venture Fund IX, L.P.Buy16.00K$1.0316.48K
2026-07-01ARCH Venture Fund IX, L.P.Sell16.00K$2.4939.84K
2026-07-01ARCH Venture Fund IX, L.P.Sell16.00K$1.0316.48K
2026-07-01TANG KEVINBuy71.61K$2.49178.31K
2026-06-30TANG KEVINBuy100$2.50250
2026-06-30TANG KEVINBuy25.93K$2.5465.86K
2026-06-29TANG KEVINBuy777$2.481.93K
2026-06-29TANG KEVINBuy63.98K$2.47158.04K
2026-06-26TANG KEVINBuy134$2.54340
2026-06-26TANG KEVINBuy75.05K$2.55191.37K
2026-06-25TANG KEVINBuy510$2.561.31K
2026-06-25TANG KEVINBuy145.88K$2.48361.78K
2026-06-25TANG KEVINOther0——
2026-06-15Whiting NancyBuy32.00K$1.4044.80K
2026-06-15Lim Jonathan EBuy48.00K$1.4067.20K
2026-06-15Christensen JamesBuy32.00K$1.4044.80K
2026-06-15Lew JenniferBuy32.00K$1.4044.80K
2026-01-23Oien JessicaBuy220.00K$1.26277.20K
2026-01-23Hassig ChristianBuy230.00K$1.26289.80K
2026-01-23Doebele RobertBuy230.00K$1.26289.80K
2026-01-23Hornby ZacharyBuy600.00K$1.26756.00K
2026-01-23HINKLE DAVID ABuy140.00K$1.26176.40K
2025-06-23Brennan ChristineBuy16.00K$1.0316.48K
2025-06-23Christensen JamesBuy16.00K$1.0316.48K
2025-06-23Lew JenniferBuy16.00K$1.0316.48K
2025-06-23Lim Jonathan EBuy24.00K$1.0324.72K
2025-06-23Burow KristinaBuy16.00K$1.0316.48K
2025-06-23Whiting NancyBuy16.00K$1.0316.48K
2025-02-03Doebele RobertBuy180.00K$2.23401.40K
2025-02-03Doebele RobertOther0——
2025-01-22HINKLE DAVID ABuy65.00K$2.57167.05K
2025-01-22Hassig ChristianBuy95.00K$2.57244.15K
2025-01-22Hornby ZacharyBuy295.00K$2.57758.15K
2025-01-22Oien JessicaBuy90.00K$2.57231.30K
2024-10-11HINKLE DAVID AOther0——
2024-10-11HINKLE DAVID AOther13.91K——
2024-08-19Hassig ChristianBuy94.87K$3.56337.74K
2024-08-19Hassig ChristianBuy76.17K$3.56271.18K
2024-08-19Hassig ChristianBuy62.82K$3.56223.64K
2024-08-19Hassig ChristianBuy48.70K$3.56173.38K
2024-08-19Hassig ChristianBuy10.26K$3.5636.51K
2024-08-19Hassig ChristianSell48.70K$16.00779.25K
2024-08-19Hassig ChristianSell76.17K$8.19623.86K
2024-08-19Hassig ChristianSell94.87K$4.10388.97K
2024-08-19Hassig ChristianSell10.26K$3.7138.05K
2024-08-19Oien JessicaBuy42.05K$3.56149.70K
2024-08-19Oien JessicaBuy35.90K$3.56127.79K
2024-08-19Oien JessicaBuy32.05K$3.56114.10K
2024-08-19Oien JessicaBuy29.15K$3.56103.77K
2024-08-19Oien JessicaBuy26.09K$3.5692.88K
2024-08-19Oien JessicaBuy16.23K$3.5657.79K
2024-08-19Oien JessicaBuy10.20K$3.5636.31K
2024-08-19Oien JessicaSell16.23K$16.00259.74K
2024-08-19Oien JessicaSell26.09K$8.19213.68K
2024-08-19Oien JessicaSell35.90K$4.49161.18K
2024-08-19Oien JessicaSell42.05K$4.10172.41K
2024-08-19Hornby ZacharyBuy471.28K$3.561.68M
2024-08-19Hornby ZacharyBuy257.21K$3.56915.66K
2024-08-19Hornby ZacharyBuy256.41K$3.56912.82K
2024-08-19Hornby ZacharyBuy162.34K$3.56577.94K
2024-08-19Hornby ZacharySell257.21K$8.192.11M
2024-08-19Hornby ZacharySell471.28K$4.101.93M
2024-08-19Hornby ZacharySell162.34K$16.002.60M
2024-08-19Abdollahian NeilBuy82.05K$3.56292.10K
2024-08-19Abdollahian NeilBuy54.87K$3.56195.34K
2024-08-19Abdollahian NeilBuy36.85K$3.56131.19K
2024-08-19Abdollahian NeilBuy23.19K$3.5682.56K
2024-08-19Abdollahian NeilBuy19.95K$3.5671.01K
2024-08-19Abdollahian NeilSell23.19K$16.00371.06K
2024-08-19Abdollahian NeilSell36.85K$8.19301.82K
2024-08-19Abdollahian NeilSell54.87K$4.10224.97K
2024-08-19Wagner Klaus W.Buy102.56K$3.56365.13K
2024-08-19Wagner Klaus W.Buy94.87K$3.56337.74K
2024-08-19Wagner Klaus W.Buy68.08K$3.56242.36K
2024-08-19Wagner Klaus W.Buy41.74K$3.56148.61K
2024-08-19Wagner Klaus W.Buy9.63K$3.5634.30K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 41, holders +5 vs prior quarter. Ownership 68.16%.

HolderSharesChangeChange %Value
ARCH VENTURE MANAGEMENT, LLC2.69M2.69MNew6.74M
FMR LLC2.58M-114.40K-4.24%6.45M
TANG CAPITAL MANAGEMENT LLC2.56M2.56MNew6.40M
ADAR1 CAPITAL MANAGEMENT, LLC1.97M1.97MNew4.92M
CORMORANT ASSET MANAGEMENT, LP1.00M1.00MNew2.50M
VANGUARD CAPITAL MANAGEMENT LLC614.92K17.73K+2.97%1.54M
WELLINGTON MANAGEMENT GROUP LLP556.23K00.00%1.39M
MILLENNIUM MANAGEMENT LLC478.64K378.76K+379.24%1.20M
RENAISSANCE TECHNOLOGIES LLC471.57K72.57K+18.19%1.18M
ALYESKA INVESTMENT GROUP, L.P.300.00K00.00%750.00K
AFFINITY ASSET ADVISORS, LLC250.00K250.00KNew625.00K
RBF CAPITAL, LLC200.00K00.00%500.00K
ENSIGN PEAK ADVISORS, INC159.84K-27.66K-14.75%399.59K
STONEPINE CAPITAL MANAGEMENT, LLC154.59K-443.09K-74.13%386.49K
ACADIAN ASSET MANAGEMENT LLC146.76K134.15K+1063.81%365.00K
CITADEL ADVISORS LLC145.05K-1.20M-89.19%362.62K
BRIDGEWAY CAPITAL MANAGEMENT, LLC128.00K77.50K+153.47%320.00K
GEODE CAPITAL MANAGEMENT, LLC116.74K-10.84K-8.50%291.84K
HRT FINANCIAL LP116.29K116.29KNew290.00K
BLACKROCK, INC.88.50K17.82K+25.21%221.24K
PRELUDE CAPITAL MANAGEMENT, LLC84.00K84.00KNew210.00K
RANGELEY CAPITAL, LLC74.00K74.00KNew185.00K
GSA CAPITAL PARTNERS LLP72.35K-24.47K-25.27%181.00K
VANGUARD FIDUCIARY TRUST CO65.14K00.00%162.84K
JANE STREET GROUP, LLC64.32K64.32KNew160.81K

Earnings and financials

Boundless Bio, Inc. (BOLD) trades at $2.50, with a market cap of $56.87M and a trailing P/E of -0.84. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20162017201820212022202320242025
00000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Boundless Bio (BOLD) Financials: Revenue & Earnings

BOLD$2.50+0.09 +3.73%

$56.87M

Market Cap

-0.84

P/E

—

Forward P/E

50

Score

Price History